Koomesh
Journal of Semnan University of Medical Sciences
Outlines
Deep vein thrombosis as the first presentation of diabetic ketoacidosis
Author(s):
Mohsen shafiepour, Majid Golestani Eraghi, Mohammadreza Shafiepour, Mehrdad Vahedian, Mehrdad Farokhnia, Masoumeh Hoseini Askarabadi,*Published online:Jun 01, 2019
Article type:Research Article
Received:Jul 01, 2018
Accepted:Oct 01, 2018
How to Cite:Mohsen shafiepourMajid Golestani EraghiMohammadreza ShafiepourMehrdad VahedianMehrdad FarokhniaMasoumeh Hoseini Askarabadiet al.Deep vein thrombosis as the first presentation of diabetic ketoacidosis.koomesh.21(2):e153084.
Abstract
References
- 1.Samama M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. the sirius study. Arch Intern Med 2000; 160: 3415-3420.
- 2.Russell MW, Taylor DC, Cummins G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002; 8: S3-9.
- 3.Chung WS, Lin CL, Kao CH. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost 2015; 114: 812-818.
- 4.Burzynski J. DKA and thrombosis. CMAJ 2005; 173: 132-133.
- 5.Deep venous thrombosis (DVT). http://emedicine.medscape.com/article/1911303-overview#a6. Last updated Jul 06, 2017.
- 6.Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48: 1017-1021.
- 7.Zhang Y, Shi Y, Ye R, Shao N, Pan F, Lin Y, et al. Diabetes mellitus-associated hyperglycemia is a risk factor for recurring deep vein thrombosis and post-thrombotic syndrome-a cohort study. Int J Clin Exp Med 2016; 9: 17739-17749.
- 8.Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. Metabolism 2002; 51: 471-476.
- 9.Murakami H, Okazaki M, Amagasa H, Oguchi K. Increase in hepatic mRNA expres-sion of coagulant factors in type 2 diabetic model mice. Thromb Res 2003; 111: 81-87.
- 10.Heit JA, Leibson CL, Ashrani AA, Petterson TM, Bailey KR, Melton LJ. Is diabetes mellitus an independent risk factor for venous thromboembolism? a population-based case-control study. Arterioscler Thromb Vasc Biol 2009; 29: 1399-1495.
- 11.Ho J, Pacaud D, Hill MD, Ross C, Hamiwka L, Mah JK. Diabetic ketoacidosis and pediatric stroke. CMAJ 2005; 172: 327-328.
- 12.Osinbowale O, Al Malki M, Schade A, Bartholomew JR. An algorithm for managing warfarin resistance. Cleve Clin J Med 2009; 76: 724-730.
- 13.Sandards of medical care in diabetes 2017. care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.../DC_40_S1_final.pdf.
- 14.Tomisti L, Del Re M, Bartalena L, Tanda M, Pucci A, Pambianco F, et al. Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature. Endocr Pract 2013; 19: 1043-1049##.
Copyright
© 2019, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
comments
Leave a comment here
Comments
Number of Comments:0Purchasing Reprints
- Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations
Author(s):
Related Articles